# Safety Study to Evaluate MN-221 in Chronic Obstructive Pulmonary Disease (COPD) Patients

> **NCT01551316** · PHASE1 · COMPLETED · sponsor: **MediciNova** · enrollment: 19 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** MN-221
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01551316
- **Lead sponsor:** MediciNova
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2012-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01551316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01551316, "Safety Study to Evaluate MN-221 in Chronic Obstructive Pulmonary Disease (COPD) Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01551316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*